Abiopharma

Clinical trial NCT01797523 updates: 1. status: ACTIVE_NOT_RECRUITING → COMPLETED 2. completion date: 2027-10-31 → 2026-02-04 3. primary completion date: 2027-10-31 → 2026-02-04

Clinical trial NCT06052631: start date: 2026-08-03 → 2026-08-04.

Clinical trial NCT04511845 updates: 1. status: ACTIVE_NOT_RECRUITING → COMPLETED 2. completion date: 2026-09-30 → 2026-06-18 3. primary completion date: 2026-09-30 → 2026-06-18 4. enrollment: 113 → 85 participants 5. enrollment type: ESTIMATED → ACTUAL

Clinical trial NCT06323356 updates: 1. status: ACTIVE_NOT_RECRUITING → COMPLETED 2. completion date: 2026-07-22 → 2026-07-10 3. primary completion date: 2025-10-15 → 2025-10-17

Clinical trial NCT03628209: completion date: 2026-04-01 → 2027-04-01.

Clinical trial NCT05754658 updates: 1. status: RECRUITING → COMPLETED 2. completion date: 2025-12-31 → 2026-07-10 3. primary completion date: 2025-12-31 → 2026-07-10 4. enrollment: 1500 → 854 participants 5. enrollment type: ESTIMATED → ACTUAL

Clinical trial NCT04784715: primary completion date: 2026-07-06 → 2026-11-11.

Clinical trial NCT06208150 updates: 1. status: RECRUITING → ACTIVE_NOT_RECRUITING 2. enrollment: 795 → 838 participants 3. enrollment type: ESTIMATED → ACTUAL

Clinical trial NCT06134362 updates: 1. status: RECRUITING → ACTIVE_NOT_RECRUITING 2. completion date: 2029-01-01 → 2029-03-14 3. primary completion date: 2029-01-01 → 2029-03-14 4. enrollment: 3508 → 2996 participants 5. enrollment type: ESTIMATED → ACTUAL

Clinical trial NCT03363373: primary completion date: 2026-06-01 → 2026-06-30.